VHCP Management’s Arcturus Therapeutics ARCT Stock Holding History

VHCP Management’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.38M	Hold	94,130	–	–	1.49%	15
2016 Q3	$1.63M	Buy	94,130 +5,085	+6%	+$164K	1.6%	13
2016 Q2	$2.8M	Buy	89,045 +19,831	+29%	+$625K	2.9%	8
2016 Q1	$1.84M	Hold	69,214	–	–	1.59%	12
2015 Q4	$3.04M	Sell	69,214 -145,072	-68%	-$6.53M	1.84%	10
2015 Q3	$9.06M	Hold	214,286	–	–	2.32%	12
2015 Q2	$9.81M	Hold	214,286	–	–	2.77%	12
2015 Q1	$8.45M	Buy	+214,286	New	+$9.43M	1.94%	13

Other funds holding ARCT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

VHCP Management's ARCT Position: Q4 2016 in Review

VHCP Management held its Arcturus Therapeutics (ARCT) position steady in Q4 2016 at 94,130 shares worth $1.38M. The position accounts for 1.49% of the portfolio, ranked #15.

VHCP Management first reported a position in ARCT in Q1 2015 and has held it in 8 quarters since. The position peaked at $9.81M in Q2 2015. 42 funds tracked by Wall St. Rank hold ARCT as of Q4 2016.

VHCP Management held 94,130 shares of Arcturus Therapeutics worth $1.38M as of Q4 2016.
VHCP Management left its Arcturus Therapeutics share count unchanged in Q4 2016.
Arcturus Therapeutics made up 1.49% of VHCP Management's portfolio in Q4 2016, its #15 holding.
VHCP Management first reported a position in Arcturus Therapeutics in Q1 2015 and has held it in 8 quarters since.
VHCP Management's Arcturus Therapeutics position peaked at $9.81M in Q2 2015.
42 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.